Revenue | ₹35.85Cr |
Net Profits | ₹0.06Cr |
Net Profit Margins | 0.17% |
Indrayani Biotech Ltd’s revenue jumped 106.99% since last year same period to ₹35.85Cr in the Q3 2025-2026. On a quarterly growth basis, Indrayani Biotech Ltd has generated -5.03% fall in its revenue since last 3-months.
Indrayani Biotech Ltd’s net profit fell -75% since last year same period to ₹0.06Cr in the Q3 2025-2026. On a quarterly growth basis, Indrayani Biotech Ltd has generated -85% fall in its net profits since last 3-months.
Indrayani Biotech Ltd’s net profit margin fell -87.92% since last year same period to 0.17% in the Q3 2025-2026. On a quarterly growth basis, Indrayani Biotech Ltd has generated -84.21% fall in its net profit margins since last 3-months.
The revenue for Indrayani Biotech Ltd in the Q3 results 2025 was ₹35.85Cr.
The net profit for Indrayani Biotech Ltd in the Q3 results 2025 was ₹0.06Cr.
The net profit margin for Indrayani Biotech Ltd in the Q3 results 2025 was 0.17%.
The revenue for Indrayani Biotech Ltd in the Q3 results 2024 was ₹17.32Cr.
The net profit for Indrayani Biotech Ltd in the Q3 results 2024 was ₹0.24Cr.
The net profit margin for Indrayani Biotech Ltd in the Q3 results 2024 was 1.39%.